Opportunity Information: Apply for CDC RFA GH12 123804CONT16

  • The HHS-CDC-CGH in the health sector is offering a public funding opportunity titled "“Expanding Comprehensive HIV Prevention Programs for People Who Inject Drugs and People Who Use Drugs in the United Republic of Tanzania under the President’s Emergency Plan for AIDS Relief (PEPFAR)” TANZANIZ" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
  • This funding opportunity was created on May 27, 2016 and posted on May 27, 2016.
  • Applicants must submit their applications by Jul 26, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: City or township governments.
Apply for CDC RFA GH12 123804CONT16

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

This funding opportunity, titled "Expanding Comprehensive HIV Prevention Programs for People Who Inject Drugs and People Who Use Drugs in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR)," is a continuation cooperative agreement issued by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC), specifically through CDC's Center for Global Health. The notice was posted on May 27, 2016, with an application closing date of July 26, 2016. It is framed as part of PEPFAR, meaning it sits within the U.S. government's broader global HIV response and is focused on scaling and strengthening evidence-based prevention approaches for populations at elevated risk of HIV acquisition and transmission in Tanzania, particularly people who inject drugs (PWID) and people who use drugs (PWUD).

The mechanism is a cooperative agreement, which matters because it signals substantial ongoing involvement by CDC in the technical direction of the work, not just a one-time grant payment. In practice, cooperative agreements typically involve CDC collaboration on program design refinements, monitoring and evaluation expectations, alignment with national and PEPFAR strategies, and ensuring that interventions meet required technical standards. The listing shows the opportunity category as "continuation," which usually indicates it is intended to extend or expand an existing, previously funded project rather than launch a completely new effort from scratch. The activity category is health, and the CFDA number is 93.067, which corresponds to CDC's global HIV/AIDS program authorities used for international HIV prevention, care, and treatment-related work.

The program purpose, as stated in the title and brief description, is to expand comprehensive HIV prevention programming for PWID and PWUD in Tanzania. Comprehensive prevention in this context generally implies a combination approach rather than a single intervention, typically integrating multiple services that reduce HIV risk and improve linkage to care. For people who inject drugs, comprehensive prevention commonly includes outreach and peer-led engagement, HIV testing services and linkage to antiretroviral therapy for those who test positive, condom promotion, sexually transmitted infection screening and treatment, and harm reduction measures that reduce transmission through unsafe injecting practices. Although the short notice does not list specific required interventions, PEPFAR and CDC harm reduction-oriented prevention for PWID often emphasizes proven strategies like safer injection education, access to sterile injecting equipment where permitted, overdose prevention integration where feasible, and strong referral pathways into medication-assisted treatment and other substance use treatment services when available. For people who use drugs more broadly (including non-injecting drug use), programs frequently focus on sexual risk reduction, consistent HIV testing, prevention commodities, risk counseling, and removing barriers to accessing general health and HIV services.

Geographically and programmatically, the opportunity is explicitly anchored in the United Republic of Tanzania and tied to PEPFAR, which typically means the work must align with Tanzania's national HIV response architecture and PEPFAR's annual planning and performance framework. PEPFAR-funded HIV prevention programs usually prioritize measurable outcomes such as increased HIV status awareness among key populations, improved linkage to treatment for HIV-positive individuals, improved retention in prevention and care services, and reductions in risk behaviors. They also commonly require robust monitoring and evaluation, routine reporting, and use of standardized indicators so results can be aggregated into national and PEPFAR reporting systems. Because PWID and PWUD are often stigmatized and face legal and social barriers, comprehensive programs also tend to include elements designed to improve access and quality, such as stigma reduction, training for healthcare workers, community-based service delivery models, and partnerships with local organizations that have credibility with the target communities.

The eligible applicant type listed for this announcement is "city or township governments," which indicates that local government entities were the intended applicant pool for this continuation action. The posting also notes an expected number of awards of one, which strongly suggests this was structured for a single recipient to carry forward and expand an ongoing program footprint, rather than fund multiple competing implementers. The award ceiling is shown as zero in the source data, which is a common artifact in some postings and does not necessarily mean the award size is literally zero; it often means the ceiling was not specified in the publicly displayed field or was determined through internal continuation funding parameters rather than a competed ceiling.

In summary, the opportunity is a CDC-issued, PEPFAR-supported continuation cooperative agreement aimed at expanding integrated HIV prevention services for PWID and PWUD in Tanzania. It is designed to build on existing efforts, with close CDC involvement, and to strengthen comprehensive, combination prevention programming and the service delivery systems that reach people who use drugs, with the overarching goal of reducing HIV transmission risk and improving connection to HIV testing, prevention, and treatment services in this high-priority population.

Frequently Asked Questions (FAQs)

What is the title of this funding opportunity?

The opportunity is titled "Expanding Comprehensive HIV Prevention Programs for People Who Inject Drugs and People Who Use Drugs in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR)."

Which U.S. government agency is offering this opportunity?

This is a U.S. Department of Health and Human Services (HHS) opportunity administered by the Centers for Disease Control and Prevention (CDC), through CDC's Center for Global Health.

What type of funding mechanism is being used?

The mechanism is a cooperative agreement. This typically means CDC has substantial ongoing involvement in the technical direction of the work, rather than providing funds with minimal federal engagement.

Is this a new grant competition or a continuation?

It is listed as a continuation opportunity, which generally indicates it is intended to extend or expand a previously funded effort rather than start a brand-new project from scratch.

What is the main purpose of the program?

The purpose is to expand comprehensive HIV prevention programming for people who inject drugs (PWID) and people who use drugs (PWUD) in the United Republic of Tanzania, as part of PEPFAR.

Which populations are the focus of this funding?

The focus is on populations at elevated risk of HIV acquisition and transmission in Tanzania, specifically people who inject drugs (PWID) and people who use drugs (PWUD).

Where will the funded activities take place?

The opportunity is explicitly anchored in the United Republic of Tanzania.

How is this opportunity connected to PEPFAR?

The funding is framed as part of the President's Emergency Plan for AIDS Relief (PEPFAR), aligning it with the U.S. government's broader global HIV response and PEPFAR planning and performance expectations.

What does "comprehensive HIV prevention" mean in this context?

Based on the description, "comprehensive" implies a combination approach (not a single intervention), integrating multiple services that reduce HIV risk and improve linkage to care for PWID and PWUD.

What kinds of services might be included for people who inject drugs (PWID)?

The notice does not list required interventions, but it describes comprehensive prevention for PWID as commonly including outreach and peer-led engagement; HIV testing services and linkage to antiretroviral therapy (ART) for those who test positive; condom promotion; sexually transmitted infection (STI) screening and treatment; and harm reduction measures to reduce transmission through unsafe injecting practices.

What kinds of services might be included for people who use drugs (PWUD) more broadly?

For PWUD (including non-injecting drug use), the description notes programs frequently focus on sexual risk reduction, consistent HIV testing, prevention commodities, risk counseling, and reducing barriers to accessing general health and HIV services.

Does the notice specify harm reduction activities?

The short notice does not list specific required interventions. However, it explains that PEPFAR and CDC harm reduction-oriented prevention for PWID often emphasizes safer injection education, access to sterile injecting equipment where permitted, overdose prevention integration where feasible, and referral pathways into medication-assisted treatment and other substance use treatment services when available.

How involved is CDC likely to be during implementation?

Because this is a cooperative agreement, the description indicates substantial CDC involvement is expected, such as collaboration on program design refinements, monitoring and evaluation expectations, and alignment with national and PEPFAR strategies and technical standards.

What is the CFDA number for this opportunity?

The CFDA number is 93.067, which corresponds to CDC global HIV/AIDS program authorities used for international HIV prevention, care, and treatment-related work.

What is the activity category for this funding?

The activity category is health.

Who is eligible to apply?

The eligible applicant type listed is "city or township governments," meaning local government entities were the intended applicant pool for this continuation action.

How many awards does CDC expect to make?

The posting notes an expected number of awards of one, suggesting the opportunity was structured for a single recipient to continue and expand an existing program footprint.

Is the maximum award amount (ceiling) stated?

The award ceiling is shown as zero in the source data. The description notes this can be a posting artifact and does not necessarily mean the award amount is literally zero; it may indicate the ceiling was not specified in the publicly displayed field or was handled through continuation funding parameters.

When was the notice posted?

The notice was posted on May 27, 2016.

What was the application closing date?

The application closing date was July 26, 2016.

What kinds of outcomes are typically prioritized for PEPFAR-supported prevention programs like this?

The description notes that PEPFAR-funded HIV prevention programs usually prioritize measurable outcomes such as increased HIV status awareness among key populations, improved linkage to treatment for HIV-positive individuals, improved retention in prevention and care services, and reductions in risk behaviors.

Are monitoring, evaluation, and reporting requirements implied?

Yes. The description states these programs commonly require robust monitoring and evaluation, routine reporting, and use of standardized indicators so results can be aggregated into national and PEPFAR reporting systems.

Does the opportunity need to align with Tanzania's national HIV response?

Yes. The opportunity is tied to PEPFAR and is described as needing to align with Tanzania's national HIV response architecture and PEPFAR's annual planning and performance framework.

Does the description address barriers faced by PWID and PWUD?

Yes. It notes that PWID and PWUD are often stigmatized and may face legal and social barriers, and that comprehensive programs tend to include elements that improve access and quality.

What kinds of access and quality improvements are mentioned?

The description provides examples such as stigma reduction, training for healthcare workers, community-based service delivery models, and partnerships with local organizations that have credibility with the target communities.

Browse more opportunities from the same agency: HHS-CDC-CGH

Browse more opportunities from the same category: Health

Next opportunity: Glen Canyon Dam Adaptive Management Program

Previous opportunity: EDUCATIONUSA STUDENT ADVISING – TUZLA

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for CDC RFA GH12 123804CONT16

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (CDC RFA GH12 123804CONT16) also looked into and applied for these:

Funding Opportunity
Strengthening and the Development of Applied Epidemiology and Sustainable Public Health Capacity through Collaboration, Program development and Implementation, Communication, and Information Sharing in the Eastern Mediterranean Region Apply for CDC RFA GH16 1704

Funding Number: CDC RFA GH16 1704
Agency: HHS-CDC-CGH
Category: Health
Funding Amount: $4,000,000
Partnering with Regional Institutes to Strengthen Essential Public Health Functions in Vietnam Apply for CDC RFA GH16 1718

Funding Number: CDC RFA GH16 1718
Agency: HHS-CDC-CGH
Category: Health
Funding Amount: Case Dependent
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24) Apply for PAR 16 301

Funding Number: PAR 16 301
Agency: HHS-NIH11
Category: Health
Funding Amount: Case Dependent
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3) Apply for PAR 16 300

Funding Number: PAR 16 300
Agency: HHS-NIH11
Category: Health
Funding Amount: Case Dependent
Programs to Reduce Obesity in High Obesity Areas to Boost Prevention Apply for CDC RFA DP16 1613

Funding Number: CDC RFA DP16 1613
Agency: HHS-CDC-NCCDPHP
Category: Health
Funding Amount: $800,000
Continuation of Immunization Information Systems (IIS) Sentinel Site Project Apply for CDC RFA IP13 13020401SUPP16

Funding Number: CDC RFA IP13 13020401SUPP16
Agency: HHS-CDC-NCIRD
Category: Health
Funding Amount: Case Dependent
Resilient and Responsive Health Systems (RRHS) Initiative Apply for HRSA 17 007

Funding Number: HRSA 17 007
Agency: HHS-HRSA
Category: Health
Funding Amount: Case Dependent
Biosensors in the Oral Cavity (R21) Apply for RFA DE 17 005

Funding Number: RFA DE 17 005
Agency: HHS-NIH11
Category: Health
Funding Amount: $200,000
Biosensors in the Oral Cavity (R01) Apply for RFA DE 17 004

Funding Number: RFA DE 17 004
Agency: HHS-NIH11
Category: Health
Funding Amount: $250,000
NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01) Apply for PAR 16 320

Funding Number: PAR 16 320
Agency: HHS-NIH11
Category: Health
Funding Amount: Case Dependent
NIDCR Mentored Career Development Award to Promote Diversity in the Dental, Oral and Craniofacial Research Workforce (K01) Apply for PAR 16 321

Funding Number: PAR 16 321
Agency: HHS-NIH11
Category: Health
Funding Amount: Case Dependent
Accelerating the Prevention and Control of HIV/AIDS, Viral Hepatitis, STDs and TB in the U.S. Affiliated Pacific Islands Apply for CDC RFA PS13 130105CONT17

Funding Number: CDC RFA PS13 130105CONT17
Agency: HHS-CDC-NCHHSTP
Category: Health
Funding Amount: Case Dependent
R40 MCH Secondary Data Analysis Research (SDAR) Apply for HRSA 17 012

Funding Number: HRSA 17 012
Agency: HHS-HRSA
Category: Health
Funding Amount: Case Dependent
R40 MCH Field-Initiated Innovative Research Studies (FIRST) Apply for HRSA 17 011

Funding Number: HRSA 17 011
Agency: HHS-HRSA
Category: Health
Funding Amount: Case Dependent
PPHF 2016: Preventive Health and Health Services Block Grant – Preventive Health and Health Services Block Grant Apply for CDC RFA OT16 1600PPHF16

Funding Number: CDC RFA OT16 1600PPHF16
Agency: HHS-CDC-OSTLTS
Category: Health
Funding Amount: Case Dependent
Emerging Science and Technology in Transplantation (U01) Apply for RFA AI 16 042

Funding Number: RFA AI 16 042
Agency: HHS-NIH11
Category: Health
Funding Amount: $250,000
Transforming Clinical Practice Initiative (TCPI) Support and Alignment Network (SAN) 2.0 Apply for CMS 1L1 16 001

Funding Number: CMS 1L1 16 001
Agency: HHS-CMS
Category: Health
Funding Amount: $2,500,000
Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R24) Apply for PAR 16 322

Funding Number: PAR 16 322
Agency: HHS-NIH11
Category: Health
Funding Amount: Case Dependent
Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases (R21) Apply for RFA HL 17 015

Funding Number: RFA HL 17 015
Agency: HHS-NIH11
Category: Health
Funding Amount: $150,000
Limited Competition: NIDCR Supplements to NCATS CTSA Programs for Scholars Pursing Dental, Oral and Craniofacial Clinical and Translational Research Career Development (Admin Supp) Apply for RFA DE 17 008

Funding Number: RFA DE 17 008
Agency: HHS-NIH11
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH12 123804CONT16", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.